• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes

    7/26/24 2:33:00 PM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email

    AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "a" (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) recently issued senior unsecured notes. (See detailed list below.) The outlook assigned to these Credit Ratings (ratings) is stable.

    The proceeds from UnitedHealth Group's recent $12 billion debt issuance are expected to be used for general corporate purposes, including repayment of outstanding commercial paper. At June 30, 2024, the company had approximately $10 billion of commercial paper outstanding. Financial leverage, as measured by AM Best, was approximately 44% at the end of second-quarter 2024. These debt issuances are expected to be neutral to financial leverage in the near term. Financial leverage should moderate but will remain over UnitedHealth Group's long-term target of 40% for the remainder of 2024. The elevated leverage is mostly driven by loans to providers affected by the Change Healthcare cyberattack. AM Best expects UnitedHealth Group's financial leverage to return to the 40% range in 2025.

    UnitedHealth Group has reported consistent revenue growth and strong operating earnings from its UnitedHealthcare and Optum business segments. Excluding the impact of the sale of its South American operations, net earnings were flat year over year despite $1 billion of tax effected cost for the Change Healthcare cyberattack. A material portion of operating cash flow is from the organization's non-regulated business, Optum operations, which continue to support overall financial flexibility. UnitedHealth Group's financial flexibility is supported further by an active commercial paper program, $21 billion revolving credit facility, parent company cash and dividends from the regulated insurance subsidiaries. UnitedHealth Group has consistently expanded its credit facility to support its growing operations and liquidity needs.

    The following Long-Term IRs have been assigned with stable outlooks:

    UnitedHealth Group Incorporated—

    -- "a" (Excellent) on $500 million floating rate senior unsecured notes, due 2026

    -- "a" (Excellent) on $650 million 4.75% senior unsecured notes, due 2026

    -- "a" (Excellent) on $1.25 billion 4.8 % senior unsecured notes, due 2030

    -- "a" (Excellent) on $1.5 billion 4.95 % senior unsecured notes due, 2032

    -- "a" (Excellent) on $2 billion 5.15% senior unsecured notes, due 2034

    -- "a" (Excellent) on $1.5 billion 5.5% senior unsecured notes, due 2044

    -- "a" (Excellent) on $2.750 billion 5.625% senior unsecured notes, due 2054

    -- "a" (Excellent) on $1.850 billion 5.75% senior unsecured notes, due 2064

    This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.

    AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

    Copyright © 2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240726748595/en/

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    1/6/2025$625.00 → $610.00Buy
    Truist
    More analyst ratings

    $UNH
    Leadership Updates

    Live Leadership Updates

    See more
    • UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

      5/13/25 5:59:56 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Charlie Baker Joins UnitedHealth Group's Board of Directors

      UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

      11/3/23 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • DNAnexus Announces Appointment of Thomas Laur as CEO

      Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol

      9/12/23 9:02:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Financials

    Live finance-specific insights

    See more
    • UnitedHealth Group Announces Leadership Transition

      Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company

      5/13/25 6:30:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, wh

      3/12/25 4:20:00 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00

      5/21/25 8:41:18 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by TD Cowen with a new price target

      TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00

      5/19/25 8:51:13 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by Raymond James

      Raymond James downgraded UnitedHealth from Strong Buy to Mkt Perform

      5/14/25 8:59:11 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO, UHG Hemsley Stephen J gifted 2,525 shares, decreasing direct ownership by 0.67% to 374,353 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/22/25 4:13:29 PM ET
      $UNH
      Medical Specialities
      Health Care
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    SEC Filings

    See more
    • UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      5/21/25 4:34:59 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by UnitedHealth Group Incorporated

      DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      5/20/25 6:01:10 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      5/14/25 6:01:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

      5/13/25 5:59:56 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Leadership Transition

      Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company

      5/13/25 6:30:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • CareXM adds Home-Based Care Industry Leader, Carla Davis, to its Board of Directors

      CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group. "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the pa

      5/7/25 8:46:00 AM ET
      $UNH
      Medical Specialities
      Health Care